REXULTI
LIVE

Serial Number

79420940

Owner

Otsuka Pharmaceutical Co., Ltd.

Attorney

Scott S. Havlick

Filing Date

Feb 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

REXULTI Trademark

Serial Number: 79420940 • Registration: 8217431

REXULTI is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on February 27, 2025. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (566 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

February 27, 2025

Registration Date

April 21, 2026

Published for Opposition

March 3, 2026

Goods & Services

Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, sold empty, for medical purposes; syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposes, namely, integrated medical systems comprising medical diagnostic imaging apparatus and downloadable software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing, and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems in the nature of medical syringes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 19, 2026 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2026 TROA
REFUSAL PROCESSED BY IB
Oct 24, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 26, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 15, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 14, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 13, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 2, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 1, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 9, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 9, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 8, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 3, 2025 SDRC